197 related articles for article (PubMed ID: 36064963)
1. Guest Edited Collection: Epigenetics within the tumor microenvironment.
Ahmad A
Sci Rep; 2022 Sep; 12(1):15089. PubMed ID: 36064963
[TBL] [Abstract][Full Text] [Related]
2. Single cell cancer epigenetics.
Casado-Pelaez M; Bueno-Costa A; Esteller M
Trends Cancer; 2022 Oct; 8(10):820-838. PubMed ID: 35821003
[TBL] [Abstract][Full Text] [Related]
3. Roadmap on plasticity and epigenetics in cancer.
Foo J; Basanta D; Rockne RC; Strelez C; Shah C; Ghaffarian K; Mumenthaler SM; Mitchell K; Lathia JD; Frankhouser D; Branciamore S; Kuo YH; Marcucci G; Velde RV; Marusyk A; Huang S; Hari K; Jolly MK; Hatzikirou H; Poels KE; Spilker ME; Shtylla B; Robertson-Tessi M; Anderson ARA
Phys Biol; 2022 Apr; 19(3):. PubMed ID: 35078159
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Crosstalk Between Epigenetics and Immunometabolism to Combat Cancer.
Seth A; Kar S
Subcell Biochem; 2022; 100():581-616. PubMed ID: 36301507
[TBL] [Abstract][Full Text] [Related]
5. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.
Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Ink Lactate Modulates Epigenomic Landscape: A Concerted Role of Pro-tumor Microenvironment and Macroenvironment During Carcinogenesis.
Sharma NK; Pal JK
Curr Mol Med; 2021; 21(3):177-181. PubMed ID: 32436828
[TBL] [Abstract][Full Text] [Related]
7. Metabolic recoding of epigenetics in cancer.
Wang YP; Lei QY
Cancer Commun (Lond); 2018 May; 38(1):25. PubMed ID: 29784032
[TBL] [Abstract][Full Text] [Related]
8. Epigenomic interplay in tumor heterogeneity: Potential of epidrugs as adjunct therapy.
Rath S; Chakraborty D; Pradhan J; Imran Khan M; Dandapat J
Cytokine; 2022 Sep; 157():155967. PubMed ID: 35905624
[TBL] [Abstract][Full Text] [Related]
9. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.
Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G
Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113
[No Abstract] [Full Text] [Related]
10. Meet the Editorial Board: a collection of insights and advice from epigenomics experts.
Johnson S
Epigenomics; 2022 Mar; 14(6):295-298. PubMed ID: 35341326
[No Abstract] [Full Text] [Related]
11. Methylation of immune synapse genes modulates tumor immunogenicity.
Berglund A; Mills M; Putney RM; Hamaidi I; Mulé J; Kim S
J Clin Invest; 2020 Feb; 130(2):974-980. PubMed ID: 31714899
[TBL] [Abstract][Full Text] [Related]
12. Understanding the epigenetic interface between the cell and the genome: a supplemental issue of DNA and cell biology on epigenetics.
Kasinski AL; Pincus Z
DNA Cell Biol; 2012 Oct; 31 Suppl 1():S1. PubMed ID: 23046452
[No Abstract] [Full Text] [Related]
13. The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment.
Qian Z; Shen Q; Yang X; Qiu Y; Zhang W
Biomed Res Int; 2015; 2015():649161. PubMed ID: 26582468
[TBL] [Abstract][Full Text] [Related]
14. Cancer epigenetics: Therapy-induced transcription is cryptically widespread.
Burgess DJ
Nat Rev Genet; 2017 Aug; 18(8):455. PubMed ID: 28649134
[No Abstract] [Full Text] [Related]
15. Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint.
Rueff J; Rodrigues AS
Methods Mol Biol; 2016; 1395():1-18. PubMed ID: 26910065
[TBL] [Abstract][Full Text] [Related]
16. Cancer Evolution: A Multifaceted Affair.
Ciriello G; Magnani L; Aitken SJ; Akkari L; Behjati S; Hanahan D; Landau DA; Lopez-Bigas N; Lupiáñez DG; Marine JC; Martin-Villalba A; Natoli G; Obenauf AC; Oricchio E; Scaffidi P; Sottoriva A; Swarbrick A; Tonon G; Vanharanta S; Zuber J
Cancer Discov; 2024 Jan; 14(1):36-48. PubMed ID: 38047596
[TBL] [Abstract][Full Text] [Related]
17. The tumor microenvironment and cancer.
Chen Z; Meng Z; Jia L; Cui R
Biomed Res Int; 2014; 2014():573947. PubMed ID: 25587537
[No Abstract] [Full Text] [Related]
18. Mutation-selection balance and compensatory mechanisms in tumour evolution.
Persi E; Wolf YI; Horn D; Ruppin E; Demichelis F; Gatenby RA; Gillies RJ; Koonin EV
Nat Rev Genet; 2021 Apr; 22(4):251-262. PubMed ID: 33257848
[TBL] [Abstract][Full Text] [Related]
19. Tumor purity and differential methylation in cancer epigenomics.
Wang F; Zhang N; Wang J; Wu H; Zheng X
Brief Funct Genomics; 2016 Nov; 15(6):408-419. PubMed ID: 27199459
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of genomic and epigenomic signatures associated with tumor immune microenvironment in hepatoblastoma.
Zhang Y; Zhang T; Yin Q; Luo H
BMC Cancer; 2021 Oct; 21(1):1156. PubMed ID: 34711185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
